Yale Pulmonologist Dr. Hilary Cain Outlines How to Improve Lung Cancer Screening Numbers in the U.S.
Lung cancer is a leading cause of death in the United States, accounting for 25 percent of cancer deaths, yet it is estimated that only 6 to 8 percent of eligible people in the U.S. are screened for the disease.
Hilary Cain, MD, says we need to do better. Cain is an associate professor of medicine (pulmonary, critical care and sleep medicine) at Yale School of Medicine, and is also the section chief of pulmonary, critical care and sleep medicine at VA CT Healthcare System, West Haven.
- October 31, 2022
As president she will work to improve the diagnosis and treatment of sleep apnea among women
- October 28, 2022
A team led by Naftali Kaminski, MD, used a newly designed molecule, called MRG-229, with potential therapeutic implications for idiopathic pulmonary fibrosis. The study is one of the first to use a microRNA mimic as a viable therapeutic in the lungs.
- October 27, 2022
Vivian Asare, MD, assistant professor of medicine (pulmonary, critical care and sleep medicine); associate medical director, Yale Centers for Sleep Medicine; and vice chief, Diversity, Equity, and Inclusion (Pulmonary, Critical Care & Sleep Medicine), has been awarded the American Academy of Sleep Medicine (AASM) Foundation Community Sleep Health grant to provide funding for the Yale Compassionate CPAP Service. The program will provide uninsured and underinsured patients equipment and assistance to offset costs of sleep apnea therapy.
- October 14, 2022
In a promising new study, a multinational team of researchers, including scientists from the Yale School of Public Health, may have found another way to identify tuberculosis. Having patients spit into a cup, then loading saliva into a commercially available testing cartridge can detect the bacteria that causes TB, they found—even though the cartridge is designed to use sputum.
- September 19, 2022
Yale pulmonologists and thoracic surgeons will be the first doctors in Connecticut to perform a next-generation bronchoscopy.
- August 26, 2022Source: YaleNews
YaleNews spoke with Carolyn D'Ambrosio for the latest edition of Office Hours, a Q&A series that introduces Yale newcomers to the broader university community.
- August 24, 2022
Following Computational Predictions, Scientists Demonstrate that Cancer Drug Counters Pulmonary Fibrosis
An experimental cancer drug with a favorable safety profile shows promise as a treatment for IPF.